Show simple item record

dc.contributor.authorBadrick, E
dc.contributor.authorSperrin, M
dc.contributor.authorRenehan, Andrew G
dc.date.accessioned2016-06-16T10:47:06Zen
dc.date.available2016-06-16T10:47:06Zen
dc.date.issued2016-05-24en
dc.identifier.citationComment on 'New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'. 2016, 114 (11):e11 Br J Canceren
dc.identifier.issn1532-1827en
dc.identifier.pmid27219288en
dc.identifier.doi10.1038/bjc.2016.99en
dc.identifier.urihttp://hdl.handle.net/10541/613324en
dc.language.isoenen
dc.rightsArchived with thanks to British journal of canceren
dc.titleComment on 'New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'.en
dc.typeArticleen
dc.contributor.departmentCenter of Health Informatics, Farr Institute@HeRC, Institute of Population Health, University of Manchester, Manchesteren
dc.identifier.journalBritish Journal of Canceren


This item appears in the following Collection(s)

Show simple item record